. Author manuscript; available in PMC: 2017 Sep 1.

Published in final edited form as: J Urol. 2016 Apr 2;196(3):703–708. doi: 10.1016/j.juro.2016.03.152

Table 2. Detailed biopsy information.

Numbers represent n (%) or median (inter quartile range)

Per patient (n=112)

Number of biopsy cores taken	14 (12,16)

Number of cores with prostate cancer	10 (7, 13)

% cores containing prostate cancer/cores taken	86% (57%, 100%)

Number of cancer cores with EPE

1	52 (46%)

2	26 (23%)

3	13 (12%)

4+	21 (19%)

% of cancer cores containing EPE/cores taken	13% (7%, 28%)

% of cancer cores containing EPE/cores cancer	16% (11%, 33%)

*Per biopsy area^ with EPE (n=183)**

% cancer in cores with EPE (n=181)	90% (60%, 95%)

Millimeter cancer in cores with EPE (n=174)	12 (8, 15)

Concomitant perineural invasion in biopsy areas with EPE	113 (62%)

Gleason score in cores with EPE (n=181)

6	8 (4.5%)

3+4	18 (10%)
4+3	31 (17%)

8	29 (16%)

9-10	95 (52.5%)

Patients could have biopsies with EPE taken from multiple areas